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ABSTRACT 
 
Aim: The aim of this literature review was to determine the reported incidence and prevalence of 
visual impairment due to stroke for all visual conditions including central vision loss, visual field 
loss, eye movement problems and visual perception problems. A further aim was to document the 
reported rate and extent of recovery of visual conditions post stroke.  
Methods: A systematic review of the literature was conducted including all languages and 
translations obtained. The review covered adult participants (aged 18 years or over) diagnosed with 
a visual impairment as a direct cause of a stroke. Studies which included mixed populations were 
included if over 50% of the participants had a diagnosis of stroke. We searched scholarly online 
resources and hand searched journals and registers of published, unpublished and ongoing trials. 
Search terms included a variety of MESH terms and alternatives in relation to stroke and visual 
conditions. The quality of the evidence was assessed using key reporting guidelines, e.g. STROBE, 
CONSORT.  
Results: Sixty-one studies (n=25,672) were included in the review. Overall prevalence of visual 
impairment early after stroke was estimated at 65%, ranging from 19% to 92%. Visual field loss 
reports ranged from 5.5% to 57%, ocular motility problems from 22% to 54%, visual inattention 
from 14% to 82% and reduced central vision reported in up to 70%. Recovery of visual field loss 
varied between 0% and 72%, with ocular motility between 7% and 92% and visual inattention 
between 29% and 78%.  
Conclusion: The current literature provides a range of estimates for prevalence of visual 
impairment after stroke. Visual impairment post stroke is a common problem and has significant 
relevance to the assessment and care these patients receive. Prospective figures regarding 
incidence remain unknown. 
 
 
Keywords: Incidence; prevalence; visual impairment; stroke; recovery; review. 
 
1. INTRODUCTION 
 
Types of visual impairment following stroke can 
be complex including ocular as well as cortical 
damage [1-6]. Visual impairment can have a 
wide ranging impact on activities of daily living, 
independence and quality of life. Links with 
depression have also been found [7-11]. Many 
studies provide information on prevalence of 
various visual conditions from their sample based 
on cross section and case note observation 
studies [12-17]. Accurate estimates of 
prevalence or incidence of visual impairment            
for stroke survivors remains unknown. 
Determination of prevalence of visual impairment 
in a stroke unit is important in order to enable 
appropriate planning of efficacious referrals to an 
eye specialist for assessment, treatment and 
targeted advice [6,18,19].  
 
The aim of this systematic literature review was 
to provide a comprehensive synthesis and 
exploration of reported evidence relating to visual 
problems after stroke with specific attention to 
incidence and prevalence. 
 
1.1 Visual Impairment Definitions 
 
Visual impairment is a deficit of visual function 
and includes abnormalities of peripheral vision, 
central vision, eye movements and a variety of 
perception problems [1,3,4,20].  
 
Visual field loss is loss of a section of the field of 
vision and can either be central or peripheral. 
Following stroke visual field loss is frequently 
homonymous, with a loss in the same half of the 
visual field of both eyes. The types of visual field 
loss can include, hemianopia, quadrantanopia, 
constriction and scotomas [20,21]. It is also 
possible to have a loss of the central area of 
vision. 
 
There are a wide range of ocular motility 
problems which can occur as a result of stroke 
including strabismus, cranial nerve palsies, gaze 
palsies, vergence abnormalities and nystagmus 
[22]. Strabismus is the misalignment of the eyes, 
which can be longstanding from childhood or 
occur as a result of an insult to the extra-ocular 
muscles or the cranial nerves supplying them.  
Eye movement palsies or pareses following 
stroke can include cranial nerve palsy, horizontal 
gaze palsy and/or vertical gaze palsy. 
Nystagmus is a continuous oscillatory movement 
of the eyes and is frequently associated in which 
both eyes move symmetrically. It may occur in 
every position of gaze or only be present in 
certain gaze positions. A further consideration is 
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that patients commonly have multiple defects 
concurrently [23].  
 
There are a number of different perceptual 
problems which can occur after stroke. The most 
recognised is visual inattention/neglect, in which 
the individual does not respond or attend to 
visual stimuli on the affected side. Other 
perceptual problems are also reported such as 
agnosia, visual hallucinations and image 
movement problems [24]. 
 
2. METHODS 
 
We conducted an integrative review, aiming to 
bring together all evidence relating to incidence, 
prevalence and recovery from stroke-related 
visual problems. The review observed and is 
reported according to the PRISMA guidelines 
(Appendix 1). This review was not registered with 
PROSPERO [25].  
 
2.1 Inclusion Criteria for Considering 
Studies for This Review 
 
2.1.1 Types of studies 
 
The following types of studies were included: 
randomised controlled trials, controlled trials, 
prospective and retrospective cohort studies and 
observational studies. Case reports and case-
controlled studies were excluded, as they 
specifically look at selected cases and are 
therefore unable to report incidence or 
prevalence. All languages were included and 
translations obtained when necessary.  
 
2.1.2 Types of participants 
 
We included studies of adult participants (aged 
18 years or over) diagnosed with a visual 
impairment as a direct result of a stroke. Studies 
which included mixed populations were included 
if over 50% of the participants had a diagnosis of 
stroke and data were available for this subgroup. 
 
2.1.3 Types of outcome and data 
 
We defined incidence as the number of new 
cases of any visual condition occurring during a 
certain period in a stroke survivor population. We 
defined prevalence as the number of cases of 
any visual condition present in a stroke survivor 
population at a certain time. We defined a 
measure of recovery as being present if 
prevalence figures were available at more than 
one time point post stroke. The visual 
impairments included are defined below. 
2.2 Visual Impairment Definitions 
 
Visual impairment is a deficit of visual function 
and includes abnormalities of peripheral vision, 
central vision, eye movements and a variety of 
perception problems [1,3,4,20].  
 
Visual field loss is loss of a section of the field of 
vision and can either be central or peripheral. 
Following stroke visual field loss is frequently 
homonymous, with a loss in the same half of the 
visual field of both eyes. The types of visual field 
loss can include, hemianopia, quadrantanopia, 
constriction and scotomas [20,21]. It is also 
possible to have a loss of the central area of 
vision. 
 
There are a wide range of ocular motility 
problems which can occur as a result of stroke 
including strabismus, cranial nerve palsies, gaze 
palsies, vergence abnormalities and nystagmus 
[22]. Strabismus is the misalignment of the eyes, 
which can be longstanding from childhood or 
occur as a result of an insult to the extra-ocular 
muscles or the cranial nerves supplying them.  
Eye movement palsies or paresis following 
stroke can include cranial nerve palsy, horizontal 
gaze palsy and/or vertical gaze palsy. 
Nystagmus is a continuous oscillatory movement 
of the eyes and is frequently associated in which 
both eyes move symmetrically. It may occur in 
every position of gaze or only be present in 
certain gaze positions. A further consideration is 
that patients commonly have multiple defects 
concurrently [23].  
 
There are a number of different perceptual 
problems which can occur after stroke. The most 
recognised is visual inattention/neglect, in which 
the individual does not respond or attend to 
visual stimuli on the affected side. Other 
perceptual problems are also reported such as 
agnosia, visual hallucinations and image 
movement problems [24].   
 
2.3 Search Methods for Identification of 
Studies 
 
We used systematic strategies to search key 
electronic databases and contacted known 
individuals conducting research in stroke and 
visual impairment. We searched Cochrane 
registers and electronic bibliographic databases 
(Appendix 2). In an effort to identify further 
published, unpublished and ongoing trials, we 
searched registers of ongoing trials, hand-
searched journals and conference transactions, 
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performed citation tracking using Web of Science 
Cited Reference Search for all included studies, 
searched the reference lists of included trials and 
review articles about vision after acquired brain 
injury and contacted experts in the field 
(including authors of included trials, and 
excluded studies identified as possible 
preliminary or pilot work). Search terms included 
a comprehensive range of MeSH terms and 
alternatives in relation to stroke and visual 
conditions (Appendix 2). 
 
2.4 Selection of Studies 
 
The titles and abstracts identified from the search 
were independently screened by two authors 
(FR, LH) using the pre-stated inclusion criteria. 
The full papers of any studies considered 
potentially relevant were then considered and the 
selection criteria applied independently by two 
reviewers (FR, LH). In the case of disagreement 
for inclusion of studies, an option was available 
to obtain a third author opinion (CN).  
 
2.5 Data Extraction 
 
A pre-designed data extraction form was used 
which gathered information on sample size, 
study design, assessments undertaken, visual 
conditions reported, timing of assessment and 
population type. Data was extracted and 
documented by one researcher (LH) and verified 
by another (FR).  
 
2.6 Data Analysis 
 
Due to the heterogeneous nature of the studies, 
a narrative analysis was undertaken. The 
exception to this was a calculation to estimate 
the prevalence of overall visual impairment 
following stroke. Strict criteria of only studies 
using consecutive recruitment from a stroke 
population and reporting an overall prevalence 
for visual impairment were used for the mean 
prevalence calculation.   
 
2.7 Quality Assessment 
 
To assess the quality of the studies included in 
this review, two checklists were considered 
relevant to the study designs in our inclusion 
criteria: the STROBE (Strengthening the 
Reporting of Observational Studies in 
Epidemiology) checklist [26,27]. The checklist 
was adapted as the original was designed to 
assess the quality of reporting rather than the 
potential for bias within a study. There is 
currently no ‘gold standard’ quality assessment 
tool for observational studies [28]. The STROBE 
Statement covers 22 items covering the whole of 
the articles from introduction, method, results 
and discussion, which are important to consider 
when assessing the quality of observation 
studies (including cohort, case-control and cross-
sectional studies). The adapted version used in 
this review included 18 items; only the 
information which is pertinent to quality appraisal 
of the studies was included. Using Boyle’s 
recommendations for the evaluation of 
prevalence studies, the items exclude which 
were not considered relevant information, such 
as the title, abstract, background, setting and 
funding [29]. 
 
3. RESULTS OF THE SEARCH 
 
The search results are outlined in Appendix 3. 
Sixty-four articles (26,321 participants) were 
included. Of the 64 included studies, none of 
which were RCTs, 52 were prospective 
observational studies and 12 were retrospective 
analyses. Consequently quality of study was 
assessed using the STROBE checklist. Although 
none of the studies were RCTs, one study was a 
retrospective analysis of data from an RCT 
archive [30]. Studies excluded from this review 
are outlined in a Appendix 4. Quality appraisal 
using the adapted STROBE checklist is outlined 
in a Appendix 5. 
 
Seven of the studies (14,573 participants) 
reported on overall visual impairment. Nineteen 
of the studies (17,924 participants) reported on 
visual field defects; 22 of the studies (4330 
participants) reported on ocular alignment and 
motility defects; nine of the studies (2097 
participants) reported on central vision problems; 
and 13 of the studies (2885 participants) reported 
on types of perceptual visual deficits following 
stroke (including visual neglect/inattention, visual 
hallucinations, agnosia and reduced stereopsis). 
Several studies reported on two or more of these 
categories.  
 
None of the studies included had a specific 
primary aim to calculate either prevalence or 
incidence of visual impairment following stroke. 
Fifty five studies were studies specifically 
investigated visual impairment following stroke, 
this included studies looking at specific visual 
problems such as visual inattention. The 
remaining 16 studies investigated symptoms and 
signs of stroke, which included reported visual 
impairment. 
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4. QUALITY OF THE EVIDENCE 
 
Three paper reported 100% of the items 
requested by the adapted STROBE checklist 
[31]. Sixteen papers reported 90% or more of the 
requested items, 51 papers reported 75% or 
more. Sixty-one reported 50% or more and three 
papers failed to reach 50%, achieving 17%, 33% 
and 39% [32-34]. Only 36% of papers reported 
limitations of their studies. Results from all 
papers were reported and the individual results 
for each paper are outlined in a Appendix 5. 
 
5. PREVALENCE AND INCIDENCE 
 
5.1 Visual Impairment 
 
Our search of the literature did not reveal any 
studies that specifically aimed to assess the 
incidence of visual impairment following stroke. 
We identified a number of studies that report an 
overall figure of prevalence for visual impairment. 
All these studies, however, were judged to have 
limitations relating to the methods of recruitment 
or assessment. Thus a calculation of incidence 
was not possible and estimates are calculated for 
prevalence.  
 
Three prospective studies of stroke populations 
(n=709) report an average prevalence of visual 
impairment post stroke of 65% ranging from 62-
71% (Table 1) [32,33,35]. These studies 
evaluated a general stroke population including 
medical and orthoptic assessments undertaken 
during the acute stroke phase within one week of 
onset to three months post stroke onset. Further 
to these three studies of general stroke 
populations, one prospective study (n=915) 
recruited a sub population of stroke survivors 
with suspected visual impairment who received 
full orthoptic assessment, typically within three 
weeks of stroke onset [6]. They reported a 
prevalence of 92% visual impairment. It is 
unknown what was missed from the general 
stroke population as not all individuals can report 
visual symptoms and referrals were evaluated to 
be more accurate when visual symptoms were 
taken into consideration in addition to ocular 
signs in comparison to ocular signs alone [36]. 
Ali et al., analysed results from a database for 
stroke survivors recruited to a variety of stroke-
related clinical trials and reported a baseline 
prevalence of 60% visual impairment [30]. This 
cohort would typically include those who are able 
and willing to participate in a clinical trial and are 
therefore, not representative of the whole 
population, for example individuals with cognitive 
impairment and aphasia are less likely to be 
recruited [37]. 
 
Three studies (n=13,541) used a stroke 
assessment tool (NIHSS ± status questionnaire) 
which only partly assesses visual function                 
[30,31,38]. The National Institute of Health 
Stroke Scale (NIHSS) is an assessment tool that 
only assesses for the presence of visual field 
loss and horizontal gaze problems [39]. Thus it is 
not a full assessment of the possible visual 
problems which can manifest as a result of 
stroke. It can therefore be argued that the 
numbers presented by these studies are not a 
true measure of overall incidence of visual 
impairment following stroke. In addition to the 
NIHSS, the Questionnaire for Verifying Stroke-
free Status (QVSFS) was used. However this 
questionnaire only asks the patient about 
painless complete or partial vision loss [40]. The 
range of overall incidence of visual problems was 
19-25.9% from these studies which was 
considerably less than studies with more 
comprehensive vision assessment methods. 
 
5.2 Visual Field Loss 
 
The reported prevalence of visual field loss after 
stroke varies considerably in the literature from 
5.5% to 57% (Table 2) and most probably due to 
its dependence on the type and affected area of 
a stroke, inclusion criteria and the timing of 
assessments and the method of testing used      
[41-44].  
 
Seven studies (n=1210) recruited stroke patients 
consecutively either as they were admitted to 
hospital acute stroke units or rehabilitation 
wards. Assessment of visual fields by 
confrontation and/or perimetry on admission after 
stroke onset detected visual field loss in up to 
57% [32,33,41,45-48]. The mean prevalence of 
visual field loss after stroke was calculated as 
31% [32,33,41,45-48]. These studies typically 
assessed patients in the acute phase with 
homonymous hemianopia or quadrantanopia 
defects most frequently detected. 
 
In addition to the above studies, seven 
prospective studies (n=15,388) of stroke sub-
populations report prevalence of visual field loss 
[21,30,43,49-51]. These sub-populations typically 
include only stroke survivors with hemianopic or 
quadrantanopic field loss or with suspected 
visual impairment of any type, or do not recruit 
consecutively. Thus reported prevalence is not 
representative of the full stroke population. 
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Prevalence of visual field loss has been 
described based on symptom reporting by 
patients in four studies (n=1362) ranging from 
14.6 to 22.7% [42,52-54]. These reports are 
considerably lower and likely reflecting the poor 
reliability of detection by patient reported 
symptoms. In addition to those formally 
diagnosed with visual field loss following stroke, 
it is important to consider how many patients are 
unaware of their visual loss. Celesia et al. 
conducted a prospective observation study 
(n=32) to investigate the presence of hemianopic 
anosognosia [54]. From a sample of thirty two 
patients with homonymous visual field loss, 62% 
were unaware of their visual deficit. In a recent 
paper it was reported that only 45% of 
participants with visual field loss reported 
symptoms of the visual field loss [36]. It is 
important to note that not all patients had isolated 
visual field loss. Multiple visual impairments 
caused by stroke were reported such as visual 
acuity loss, eye movement abnormalities and 
perceptual difficulties. This discrepancy between 
those who do not complain of symptoms and 
have a diagnosis of visual field loss may highlight 
an under estimation in the incidence in this and 
other studies.   
 
For studies whose population samples have 
solely included patients with visual field loss post 
stroke, it is not possible to establish prevalence. 
However, several of these studies have shown 
almost equal numbers suffering right or left 
defects [34,44,55,56]. 
 
5.3 Ocular Motility/Strabismus  
 
Three prospective studies (n=1262) reported an 
average prevalence of all ocular motility 
problems as 33% (Table 3) with a range from 
22% to 54%, [18,35,57]. Assessments were 
usually within the acute period and two studies 
used detailed orthoptic evaluation of eye 
movements and binocular vision [18,35]. 
Methods of ocular motility assessment are 
important to the accuracy of identification of eye 
movement abnormalities to ensure full detection 
of deficits in various gaze positions. 
 
5.3.1 Eye alignment  
 
Strabismus may occur as an isolated finding or in 
association with ocular motility problems and is 
reported in 16.5% to 52% of stroke survivors 
recruited to three prospective observation studies 
(n=626), with an average prevalence of 38% 
[32,35,58]. These studies used validated 
orthoptic assessments to detect presence of 
strabismus, increasing their accuracy of 
detection. In a sub-population prospective multi-
centre observational study, 19% of the sample 
were identified with strabismus [23]. Pre-existing 
strabismus was acknowledged in 2.5%, thus 
16.5% were considered to be a direct result of 
stroke. The cause of the strabismus in 70% of 
cases was an ocular motility defect. Only 36% 
were symptomatic with diplopia, which highlights 
an issue in relying purely on symptoms alone. 
This study has a risk of under-estimating the 
prevalence, as the sample is not representative 
of the whole stroke population. 
 
Diplopia is reported as a symptom in many 
papers which is a result of a misalignment of the 
eyes and a disruption of binocular vision. Other 
studies have highlighted the discrepancy 
between patients who do or do not report 
diplopia in the presence of strabismus or ocular 
motility defects. There is a risk that a proportion 
is not captured, if the symptom of diplopia is 
relied upon to identify ocular motility defects. The 
majority of studies reporting the incidence of 
diplopia limit recruitment to include strokes 
affecting specific areas of the brain [43,59,60], 
are retrospective [42,53] or required informed 
consent [61]. These studies cannot be 
generalised to the whole stroke population and 
also carry a risk of under estimating the true 
prevalence of strabismus. 
 
5.3.2 Eye movement palsy 
 
Seven studies (n=2783) report figures for gaze 
palsies including horizontal and/or vertical gaze 
positions and have a mean prevalence following 
stroke of 26% (range 18-44%) [22,32,35,43, 
57,62,63]. These defects may occur in isolation 
or in conjunction with other visual problems,            
and are the most common of all ocular              
motility abnormalities [22,57]. Horizontal gaze              
palsies are more prevalent than vertical and 
complete palsies more prevalence than partial 
[22,32,35,63].  
 
Cranial nerve palsies affecting the ocular motor 
muscles include third, fourth and sixth nerves 
with a mean post-stroke prevalence of 16% 
(range 3 to 39%) from three studies (n=2329) 
[18,32,43,57]. Third nerve and sixth nerve 
palsies are reported as being more prevalent 
than fourth nerve palsies in these stroke 
populations [18,32,64]. Where ocular movement 
assessment only tests horizontal gaze          
(such as with the NIHSS screening tool) the 
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identification of all ocular cranial nerve palsies is 
limited. It is likely that more subtle nerve palsies 
and those involving the vertical muscles may be 
missed. 
 
5.3.3 Nystagmus 
 
Following stroke, nystagmus is reported in an 
average of 11% (range 4 to 48%) in three studies 
(n=438) [35,62,65]. In most prospective and 
retrospective studies reporting nystagmus, the 
specific types of nystagmus are not reported. 
This, in addition to lack of information regarding 
the method of assessment, makes it difficult to 
assess if the more subtle types, or nystagmus 
not present in primary position, have been 
missed. These factors increase the risk of an 
underestimation of prevalence. When reported, 
common types of acquired nystagmus are gaze 
evoked, multi-vector and upbeat [66]. The 
studies described to date, frequently report when 
the stroke has affected the posterior circulation, 
including the cerebellum [42,60,67,68]. No 
studies have reported the prevalence of 
nystagmus in anterior circulation strokes in 
isolation. It is, therefore not possible to estimate 
the proportion of cases which are potentially 
missed by restricting populations to posterior 
circulation strokes only. 
 
5.3.4 Vergence 
 
Clisby (n=140) reported 55% of patients to have 
reduced convergence and/or stereopsis [32]. 
Rowe et al. (n=243) reported reduced 
convergence from the initial ten month data           
set of the Vision in Stroke (VIS) study [69]. Using 
the gold standard ‘normal’ attainment for 
convergence of 6cm, 54% were judged to have 
reduced convergence. However, they also 
reported that 26% had convergence reduced less 
than 10cm, which could be judged to be a more 
appropriate standard for an older group of 
patients. Siong et al. reported 21% of the 
recruited population to have convergence 
reduced less than 15 cm [61]. 
 
5.4 Visual Acuity and Central Vision 
Deficit 
 
Clinical assessment of visual acuity has been 
used to identify those with reduced vision and up 
to 70% of stroke survivors (Table 4) have been 
noted to have poor central vision [32,36,64,70]. 
The mean prevalence of reduced visual acuity 
post-stroke was calculated from three studies 
(n=270) as 53% [32,64,70]. Methods include 
visual acuity assessment at near, a 3 or 6 metre 
distance. Further retrospective studies (n=447) 
provide information on the prevalence of patients 
reporting symptoms associated with a reduction 
of visual acuity [42,53]. A key issue identified by 
three studies (n=1045) related to patient glasses 
[36,64,70]. These were frequently reported as 
missing, or the glasses present were dirty, 
broken or the wrong prescription.  
 
An important component of central visual 
function is contrast sensitivity, the reduction of 
which can deform image perception. Contrast 
sensitivity function has been reported to be 
abnormal in 62% of stroke patients (n=16) [71]. 
Different areas of the spectrum are impaired 
depending on the lesion site. For example, 
participants with parietal and temporal lesions 
have been reported to have reduced detection of 
low spatial frequencies whereas those with 
occipital and occipito-temporal lesions had 
difficulty with medium to high spatial frequencies 
[71]. Furthermore, reduced contrast sensitivity in 
stroke survivors, particularly those with severe 
functional difficulties, has been found to be 
associated with reduced activities of daily living 
[72]. 
 
Central vision is key to activities such as reading. 
However, reading difficulties may be caused by a 
wide range of visual impairments in addition to 
reduced visual acuity. Rowe et al. (n=915) 
reported difficulties with reading occurred in 
19.3% of the sample [19]. The three largest 
associations with reading difficulties were visual 
field loss (61.6%, the majority of which were 
complete homonymous hemianopia), reduced 
convergence of less than 6 cm (45.8%) and 
saccadic abnormalities (45.0%). Other visual 
impairments associated with reading difficulties 
included reduced visual acuity (22.5%), 
perceptual deficits (22%), including 16.5% with 
visual inattention, nystagmus (12.4%) and 
diplopia (8.5%).  
 
5.5 Visual Perception Abnormalities 
 
The commonest form of visual perception 
disorder following stroke is visual neglect or 
inattention. The literature reporting the 
prevalence of visual neglect/inattention can be 
difficult to interpret. Often the different types of 
inattention (e.g. auditory, visual, and spatial) are 
not separated, so it is not always possible to 
isolate visual inattention. 
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Table 1. Overall visual impairment prevalence 
 
Study Design Population Time of vision 
assessment 
Sample size 
(n=) 
Prevalence of 
visual issue (%) 
Co-existent 
ocular condition 
Method of visual 
assessment 
1974; Isaeff  
et al. [33] 
Prospective 
observation 
General stroke Median within 3 
months of onset 
322 62 Yes Medical 
1987; 
Freeman & 
Rudge [35] 
Prospective  
observation 
General stroke Median within 1 week 
of onset 
247 63 Yes Medical  
Orthoptic 
1995; Clisby 
[32] 
Prospective 
observation 
General stroke Acute period on 
stroke unit 
140 71 Yes Orthoptic 
2007; Barrett  
et al. [38] 
Prospective 
observation 
General stroke Unknown 505 19 Unknown NIHSS and 
Questionnaire for 
verifying stroke-
free status  
2009; Rowe  
et al. [6] 
Prospective 
observation 
Stroke survivors 
with suspected 
visual issues 
Median within 3 
weeks of onset 
323 92 Yes Orthoptic 
2013;  
Ali et al. [30] 
Trial data Acute stroke Median within 1 week 
of stroke onset 
11900 60 Unknown NIHSS 
2010; Gall  
et al. [31] 
Retrospective General stroke Unknown 1136 25.9 
23–male 
29–female 
Unknown NIHSS 
 
Table 2. Visual field loss prevalence 
 
Study Design Population Time of vision 
assessment 
Sample size 
(n=) 
Prevalence of visual  
issue (%) 
Co-existent 
ocular 
condition  
Method of visual 
field assessment 
1973; 
Haerer  
et al. [47] 
Prospective 
observation 
General stroke Unknown 265 25 – homonymous 
hemianopia/ 
quadrantanopia 
Unknown Confrontation 
1974; 
Isaeff  
et al. [33] 
Prospective 
observation 
General stroke Median within 3 
months of onset 
322 17 – visual field loss Ocular 
pathology 
Confrontation 
1989; 
Gray  
Prospective 
observation 
General stroke Followed every 24 
hours for 4 days 
174 56.9 – homonymous 
hemianopia 
Ocular 
pathology 
Confrontation 
 
  
 
 
Hepworth et al.; OR, 5(1): 1-43, 2016; Article no.OR.21767 
 
 
 
9 
 
Study Design Population Time of vision 
assessment 
Sample size 
(n=) 
Prevalence of visual  
issue (%) 
Co-existent 
ocular 
condition  
Method of visual 
field assessment 
et al. [41] and max to 28 days 46.6 – hemianopia 
10.3 – quadrantanopia 
1993; 
Benedetti 
et al. [48] 
Prospective 
observation 
General stroke Median within 48 
hours of admission 
94 19.1 – homonymous 
hemianopia 
Unknown Unknown 
1995; 
Clisby [32] 
Prospective 
observation 
General stroke Acute period on 
stroke unit 
140 47 – visual field loss Ocular 
pathology 
Confrontation 
Campimetry  
1997; 
Agrell  
et al. [45] 
Prospective 
observation 
General stroke Median within 3 
months of onset 
67 30 – homonymous 
hemianopia 
Visual 
inattention 
Confrontation 
1997; 
Celesia 
et al. [54] 
Prospective 
observation  
Stroke survivors 
with hemianopia 
Median within 24 
hours of onset 
32 100 – homonymous 
hemianopia 
62 – asymptomatic 
Unknown Kinetic perimetry 
2000; 
Lotery  
et al. [64] 
Prospective 
observation 
General stroke Median within 3 
months of onset 
77 19.5 – visual field loss 
¾ hemianopia 
Ocular 
pathology 
Unknown 
2001; 
Cassidy et 
al. [46] 
Prospective 
observation 
General stroke Median within 3 
months of onset 
148 50.6 - visual field loss Ocular 
pathology 
Confrontation 
Perimetry 
2007; 
Townsend 
et al. [51] 
Prospective 
observation 
General stroke 
excluding 
receptive aphasia 
and cognitive 
impairment 
Within 9 months of 
onset 
61 16 – homonymous 
hemianopia 
Unknown Static perimetry 
2009; 
Rowe  
et al. [6] 
Prospective 
observation 
Stroke survivors 
with suspected 
visual issues 
Median within 3 
weeks of onset 
915 49.5 – visual field loss 
⅔ hemianopia 
1/2 asymptomatic 
Ocular 
pathology 
Visual 
inattention 
Confrontation 
Kinetic perimetry 
Static perimetry 
2012; Tao 
et al. [43] 
Prospective 
observation 
General stroke: 
anterior vs 
posterior 
circulation 
Median within 3 
months of onset 
1174 6.9 – visual field loss 
Hemianopia: 
4.3 – posterior circulation 
1.3 – anterior circulation 
Quadrantanopia:1.3 – 
posterior circulation 
Unknown NIHSS 
Confrontation 
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Study Design Population Time of vision 
assessment 
Sample size 
(n=) 
Prevalence of visual  
issue (%) 
Co-existent 
ocular 
condition  
Method of visual 
field assessment 
2013; Ali 
et al. [30] 
Prospective trial 
data 
General stroke Median within 1 
week of stroke 
onset 
11900 51 – visual field loss: 
majority hemianopia 
Unknown NIHSS 
Confrontation  
2013; 
Rowe et 
al. [21] 
Prospective Stroke survivors 
with suspected 
visual impairment 
Variable over 2 
weeks to 6 months 
915 52.3 – visual field loss 
54 – complete 
homonymous hemianopia 
19.5 – partial 
homonymous hemianopia 
15.2-homonymous 
quadrantanopia 
0.2 – temporal crescent 
9.2– constricted fields 
5.1 – scotomas 
1.7 – bilateral hemianopia 
Yes Confrontation 
Static perimetry 
Kinetic perimetry 
2014; 
Siong et 
al. [61] 
Prospective 
observation 
General stroke 10 days to 26 years 
post stroke onset 
113 26.5 – monocular defects 
11.5 – binocular defect 
Ocular 
pathology 
Confrontation 
2001; 
Lawrence 
et al. [49] 
Retrospective Stroke register Median within 3 
months of onset 
1136 26.1 – visual field loss Unknown Unknown 
2002; 
Rathore et 
al. [52] 
Retrospective  Database stroke 
cohort 
Unknown  474 14.6 – homonymous 
hemianopia 
Unknown Unknown 
2005; Ng 
et al. [50] 
Retrospective  Posterior 
circulation strokes 
Unknown 89 53 – visual field loss Unknown  Unknown  
2011; 
Jerath  
et al. [53] 
Retrospective  General stroke 
Male vs female 
Unknown 449 22.7 – visual field loss 
(female) 
20.9 – visual field loss 
(male) 
Unknown Neurology 
Accident & 
Emergency 
assessment 
Non-standardised 
2012; 
Searls 
 et al. [42] 
Retrospective  Posterior 
circulation stroke 
Unknown 407 22 – visual field loss Unknown Neurology 
assessment of 
signs and 
symptoms  
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Table 3. Eye movement disorder prevalence 
 
Study Design Population Time of vision 
assessment 
Sample 
size (n=) 
Prevalence of visual 
issue (%) 
Co-existent 
ocular condition  
Method of 
assessment 
1975; Yap  
et al. [57] 
Prospective 
observation 
General stroke Median within 2 
days of onset 
100 44 – ocular motility 
disorders 
28 – gaze palsy 
11 – impaired VOR 
6 – cranial nerve palsy 
Unknown Unknown  
1982; De 
Renzi  
et al. [62] 
Prospective 
observation 
General stroke Follow-up every 3-
4 days for 2 weeks 
post onset 
91 28 – horizontal gaze 
palsy 
7 - nystagmus 
Unknown NIHSS 
1987; 
Freeman & 
Rudge [35] 
Prospective 
observation 
General stroke Median within 1 
week of onset 
247 22 – ocular motility 
disorders 
35 – strabismus 
(additional 6% pre-
existent) 
18 – palsies 
(skew deviation:3 
1 ½ syndrome 6 
Horizontal gaze palsy 
57% 
Vertical gaze palsy 20%] 
23 - nystagmus 
Yes Medical 
Orthoptic  
1995; Clisby 
[32] 
Prospective 
observation 
General stroke Acute period on 
stroke unit 
140 52 – strabismus 
44 – gaze palsy: 
90 – horizontal with right 
hemisphere stroke 
73 – horizontal with left 
hemisphere stroke 
39 – cranial nerve palsy 
(mainly III) 
55- reduced vergence 
and stereoacuity 
Ocular pathology Orthoptic  
1996; Fowler 
et al. [58] 
Prospective 
observation 
Mixed 
neurological on 
Median within 2 
months of 
239 (54% 
stroke ) 
26 – stroke-related 
strabismus 
Unknown Orthoptic  
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Study Design Population Time of vision 
assessment 
Sample 
size (n=) 
Prevalence of visual 
issue (%) 
Co-existent 
ocular condition  
Method of 
assessment 
rehabilitation unit admission 
2000; Lotery 
et al. [64] 
Prospective 
observation 
General stroke Median within 2 
weeks of onset 
77 2.6 – third nerve palsy Yes Ophthalmology 
and optometric 
2006; Singer 
et al. [63] 
 
Prospective Sub population 
excluding 
haemorrhagic 
stroke and 
posterior 
circulation 
ischaemia 
Within 6 hours of 
onset 
116 26.7 – complete gaze 
palsy 
0.6 – partial gaze palsy 
Unknown NIHSS 
2007; Rowe 
et al. [70] 
Prospective 
observation 
Stroke survivors 
with suspected 
visual 
impairment 
Median within 3 
weeks of onset 
243 54 – reduced 
convergence <6cms. 
26 – reduced 
convergence <10cms.  
Yes Orthoptic 
2008; Rowe  
et al. [66] 
Prospective 
observation 
Stroke survivors 
with suspected 
visual 
impairment 
Median within 3 
weeks of onset 
323 12 – nystagmus 
N=2 – pre-existent 
N=18 – oscillopsia/vertigo 
symptoms 
Yes Orthoptic 
2009; 
Siddique et 
al. [65] 
Prospective General stroke Acute period 100 4 - nystagmus Unknown Unspecified 
protocol 
2009; Akhtar 
et al. [68] 
Prospective Posterior 
circulation stroke 
only 
Acute period 116 48 – nystagmus Unknown Unknown  
2009; Rowe 
et al. [24] 
Prospective 
observation 
Stroke survivors 
with suspected 
visual 
impairment 
Median within 3 
weeks of onset 
323 54 – reduced 
convergence <6cms 
26 – reduced 
convergence <10cms 
Yes Orthoptic 
2010; Rowe 
et al. [23] 
Prospective 
observation 
Stroke survivors 
with suspected 
visual 
impairment 
Median within 3 
weeks of onset 
512 19 – strabismus 
16.5 – new onset 
2.5 – pre-existent 
Yes Orthoptic 
2011; Rowe 
et al.  
Prospective 
observation 
Stroke survivors 
with suspected 
Median within 3 
weeks of onset 
915 54 – ocular motility 
disorders 
Yes  Orthoptic  
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Study Design Population Time of vision 
assessment 
Sample 
size (n=) 
Prevalence of visual 
issue (%) 
Co-existent 
ocular condition  
Method of 
assessment 
[18, 19] visual 
impairment 
2/3 – diplopia 
19 – strabismus (2.5% 
pre-existent) 
10 – cranial nerve palsy 
(VI>III>IV) 
58 – VI 
26 - III 
2011; Baier 
& Dieterich 
[67] 
Prospective Cerebellar stroke Mean within 6 days 21 33 – nystagmus Unknown Eye movement 
recording 
2012; 
Maeshima et 
al. [59] 
Prospective 
observation 
Pontine stroke Unknown 68 15.9 – diplopia Unknown Unknown 
2012; Tao et 
al. [43] 
Prospective 
observation 
General stroke: 
Anterior vs 
posterior 
circulation stroke 
Acute period 1174 8 – diplopia: 
7.3 posterior circulation 
0.7 anterior circulation 
13.5 – gaze palsy: 
11 – anterior circulation 
2.6 – posterior circulation 
4 – cranial nerve palsy: 
posterior circulation 
Unknown NIHSS 
2013; Su & 
Young [60] 
Prospective 
observation 
Posterior fossa 
stroke: vertigo 
clinic 
Unknown 70 31 – ocular motility 
disorders 
45 – diplopia 
N=22 – nystagmus 
[45.5% multidirectional 
54.5 unidirectional 
86 - reduced OKN] 
Unknown Nystagmus – eye 
movement 
recordings 
2013; Rowe 
et al. [22] 
Prospective 
observation 
Stroke survivors 
with suspected 
visual 
impairment 
Median within 3 
weeks of onset 
915 23 – gaze defect: 
15.9 – horizontal and 
vertical gaze palsy 
69.7 – complete 
13.5 – saccadic palsy 
22.2 – smooth pursuit 
Yes Orthoptic 
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Study Design Population Time of vision 
assessment 
Sample 
size (n=) 
Prevalence of visual 
issue (%) 
Co-existent 
ocular condition  
Method of 
assessment 
palsy 
22.2 – impaired gaze 
holding 
3.9 – Parinaud’s 
syndrome 
9.7 – INO 
1.4 – one and a half 
syndrome 
2014; Siong 
et al. [61] 
Prospective 
observation 
General stroke 10 days to 26 
years post stroke 
onset 
113 53.1 – jerky eye 
movements 
11.5 – restricted ocular 
motility 
20 – reduced 
convergence (<15cm) 
Yes Optometrist 
2011; Jerath 
et [53] 
Retrospective General stroke 
Male vs female 
Unknown 449 7.8 – diplopia (7.1% 
male, 0.7% female) 
17.5 – nystagmus 
(4.6 male, 12.9 female) 
Unknown Neurology 
Accident & 
Emergency 
assessment 
Non-
standardised 
2012; Searls 
et al. [42] 
Retrospective Posterior 
circulation stroke 
Unknown 407 20 – ocular motility 
disorders 
15 – diplopia 
25 – nystagmus 
Unknown Neurology 
assessment of 
signs and 
symptoms 
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Table 4. Central visual deficit prevalence 
 
Study Design Population Time of vision 
assessment 
Sample 
size (n=) 
Prevalence of visual 
issue (%) 
Co-existent 
ocular 
condition  
Method of 
assessment 
1989; 
Bulens et 
al. [71] 
Prospective 
observation 
General stroke Days to years post 
onset 
16 62 – reduced contrast 
sensitivity 
No Ophthalmology 
1995; 
Clisby [32] 
Prospective 
observation 
General stroke Acute period on 
stroke unit 
140 58 – reduced visual 
acuity 
Excluded 
ocular 
pathology 
Orthoptic with 
adapted visual acuity 
assessment for 
dysphasia 
2000; 
Lotery  
et al. [64] 
Prospective 
observation 
General stroke Median within 2 
weeks of onset 
77 30 – visual acuity ≤6/12 
27 – no glasses 
available, dirty or 
damaged lenses 
Yes Ophthalmology and 
optometric 
2006; 
Edwards et 
al. [70] 
Prospective 
observation 
General stroke with 
exclusions if 
unable to hold a 
pencil or severe 
motor or language 
deficits 
Median within 15 
days of onset 
53 70 – reduced visual 
acuity 
30 – 6/7.5-6/15 
4 – 6/21-6/30 
36 – 6/60-6/120 
54 – no glasses 
available 
Unknown Near visual acuity 
2011; Rowe 
et al. [19] 
Prospective 
observation 
Stroke survivors 
with suspected 
visual impairment 
Median within 3 
weeks of onset 
915 19.3 – reading 
impairment: 
61.6 – field loss 
45.8 – reduced 
convergence 
45 – saccadic defects 
22.5 – reduced visual 
acuity 
22 – perceptual defect 
Yes Orthoptic 
2013a; 
Rowe et al. 
[36] 
Prospective 
observation 
Stroke survivors 
with suspected 
visual impairment 
Median within 3 
weeks of onset 
915 31 – reduced visual 
acuity 
Yes Orthoptic 
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Study Design Population Time of vision 
assessment 
Sample 
size (n=) 
Prevalence of visual 
issue (%) 
Co-existent 
ocular 
condition  
Method of 
assessment 
2011; 
Jerath et al. 
[53] 
Retrospective General stroke 
Male vs female 
Unknown 449 27 – loss of vision 
reported: 
15.8 – male 
10.3 - female 
19 – visual disturbance 
reported: blurred vision, 
focus difficulty, 
photophobia, visual 
hallucinations 
Unknown Neurology 
Accident & 
Emergency 
assessment 
Non-standardised 
2012; 
Searls et al. 
[42] 
Retrospective Posterior 
circulation stroke 
Unknown 407 20 – blurred vision Unknown Neurology 
assessment of signs 
and symptoms 
2012; dos 
Santos & 
Andrade 
[72] 
Retrospective General stroke with 
haemorrhagic 
stroke excluded 
 40 100 – reduced contrast 
in comparison to 
controls 
Excluded 
ocular 
pathology 
 
Ophthalmology 
2014; Siong 
et al. [61] 
Prospective 
observation 
General stroke 10 days to 26 
years post stroke 
onset 
113 29.8 – vision worse 
than 0.3 LogMAR 
11.5 – mild reduced 
vision (worse than 0.5 
LogMAR) 
1.8 – moderate 
reduced vision (worse 
than 1.0 LogMAR) 
Yes Optometrist 
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Visual inattention has been reported on average 
in 32% (range 14% to 82%) (Table 5) of stroke 
survivors from five studies (n=1800) [56,73-76]. 
These studies have recruited participants 
consecutively and have used a range of tests or 
tools for visual inattention including cancellation 
tests and the Behavioural Inattention Test. 
Studies (n=1335) using cancellation tests alone 
reported prevalence of 15% to 26% [73,75,77]. 
Those using a variety of assessments (n=991) 
for visual inattention reported a prevalence of 
14% to 82% [56,74,78-81]. Discrepancies in            
the wide range of prevalence figures typically 
related to the timing of assessment plus 
inclusion/exclusion criteria of left versus right 
sided stroke lesions and severe cognitive and/or 
communication deficits. As expected, there was 
a greater prevalence of left versus right sided 
inattention. 
 
In addition to visual neglect/inattention, the 
prevalence of other perceptual deficits are 
reported in the literature. Perceptual deficits, 
such as object agnosia, colour detection 
difficulties have been reported in the literature in 
very small numbers [19,23,24,81]. Our literature 
search found four studies reporting an estimated 
prevalence for different visual perceptual deficits 
following stroke [24]. Beaudoin et al. (n=189) 
reported an overall prevalence of visual 
perception deficits as 49.2% [82]. Rowe et al. 
(n=323) estimated the prevalence as 20%, of 
which the prevalence of visual hallucinations 
after stroke was 4% and visual agnosia was 
2.5% [24]. It was reported that patients with 
visual hallucinations and other perceptual deficits 
frequently do not disclose these symptoms. This, 
in addition to the method of recruitment could 
result in an under-estimation of the true 
prevalence. Yang et al. (n=82) reported 50% of 
participants had pathologic (>3º) subjective 
visual vertical tilt following brainstem stroke [83]. 
Chechlacz et al. (n=454) reported 28% of 
participants with right hemisphere stroke showed 
left visual extinction versus 6.8% of participants 
with left hemisphere stroke showed right visual 
extinction [84].  
 
Freeman and Rudge reported 79% of 
participants to have defective stereopsis [35]. 
Stereopsis was only tested in the pilot study 
(n=26), therefore the number of participants 
tested was limited to 19. It was also purposely 
not tested on participants with manifest 
strabismus even those which were a direct result 
of the stroke. The majority of those with 
strabismus would not demonstrate any 
stereopsis. This would result in an 
underestimation of those suffering reduced or 
absent stereopsis as a direct result of stroke. 
 
6. RECOVERY OF VISUAL FUNCTION 
 
Our literature search identified just one study that 
appears to report the recovery of overall visual 
problems following stroke (Table 6). The majority 
that report recovery do so for visual field loss 
(Table 7). Ali et al. had the largest sample for 
tracking recovery of multiple visual problems 
following stroke [30]. However, not all visual 
problems were included due to the use of the 
NIHSS which limits assessment to visual field 
loss and horizontal gaze paresis. There was a 
variable sample size at the three time points 
used (baseline, 30 days and 90 days post 
stroke). The authors reported a reduction of 
visual problems to 28.2% at 30 days and a 
further reduction to 20.5% at 90 days, compared 
to the initial 60.5% at baseline. The sample size 
considerably decreased between baseline 
(n=11,900) to 30 days post stroke (n=4,965).   
 
6.1 Visual Field Loss 
 
Recovery of visual field loss is reported by a 
number of studies but across variable time 
periods (Table 7). The percentage of patients 
recovering from visual field loss ranges from 0% 
to 44% for complete recovery and up to 72.2% 
for partial recovery (n=6656) [30,35,41,46,55,              
85-87]. Variability in recovery rates appears to be 
dependent on time of baseline assessment and 
length of follow-up, accuracy of visual field 
assessment methods and their sensitivity to 
detection of change, prospective versus 
retrospective studies and exclusions of severe 
neurological and communication defects.  
 
Gray et al. (n=174) documented recovery in 
47.8% of their sample, with a slightly higher 
proportion of 56.5% who had suffered a right 
hemianopia [41]. The macula was involved in 
56.3% of the sample; 72.2% seeing an 
improvement in this and surrounding areas. They 
noted four different patterns of recovery, the 
most common (34.4%) of which was recovery of 
the lower quadrant. This was followed by 
complete recovery (25%), recovery of the upper 
quadrant (21.9%) and finally improvement in both 
quadrants with some residual defect (18.7%). 
They found that most improvement occurred 
between 6 and 25 days post stroke. Cassidy et 
al. (n=19) reported that of those patients who 
demonstrated some recovery, only 15.8% 
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achieved complete recovery at four weeks [46]. 
The majority of 42.1% had some central recovery 
and the remainder had quadrantic recovery.            
For a patient with complete homonymous 
hemianopia the recovery of the macula area can 
appear to be only a small recovery. However, 
this can have a considerable functional impact 
such as with reading ability. They were also able 
to demonstrate the reduced sensitivity of the 
confrontation method at detecting areas of 
recovery. Variances in reports related to   
whether the baseline visual field loss was 
complete or partial and/or congruous versus 
incongruous loss along with stroke-specific or 
mixed populations. 
 
6.2 Ocular Motility Abnormalities and 
Strabismus 
 
Less has been reported on the recovery of ocular 
alignment and motility problems following a 
stroke (Table 8). The percentage of patients 
which were reported to recover ranged from 7% 
to 28.5% for full recovery and up to 92% for 
partial recovery (n=6047) [18,22,30,35,62,66]. 
The greatest recovery was for reduced 
stereoacuity at 92% [35]. Sixth nerve palsies 
were reported to have the highest incidence of 
complete recovery of cranial nerve palsies at 
28.5% [18]. At least one third showed no 
recovery across ocular motility conditions of gaze 
palsy, nystagmus, cranial nerve palsy and 
strabismus [18,19,35,66]. 
 
6.3 Visual Acuity and Central Vision 
Deficit 
 
Little is reported on the recovery of vision 
following stroke (Table 9). We found one study 
(n=247) that outlined the recovery of reduced 
vision following stroke [35]. The majority (71%) 
showed some recovery. It is not clear from this 
paper what extent of recovery was made and 
whether this had been achieved at the one or six 
month follow-up.  
 
Rowe et al. (n=915) reported the recovery rates 
for a group of participants suffering reading 
difficulties [19]. The data from follow-up         
visits was available for 42.9% of the participants. 
Of these, 10.5% had complete resolution of    
their symptoms, and 43.4% showed             
some improvement. A similar proportion of 
44.7% saw no change in their symptoms and 
only 1.3% experienced deterioration in their 
condition. 
 
6.4 Visual Perception abnormalities 
 
6.4.1 Visual inattention 
 
Four studies (n=5286) have reported recovery of 
visual neglect/inattention [30,35,79,88]. The 
percentage of recovery reported in the literature 
ranges from 29% to 78% (Table 10). In contrast 
to other visual impairments, patients suffering 
with visual neglect were more likely to require a 
longer stay in hospital and have a poorer 
prognosis for recovering function [73]. Recovery 
is mostly seen within 3 months post onset 
[30,35,79] with approximately 10% full recovery 
within the first 2 weeks [90].  
 
6.4.2 Other perceptual deficits 
 
One study (n=140) was found to report the 
recovery of visual hallucinations [89]. The 
authors reported that visual hallucinations 
(Charles Bonnet syndrome) persisted for several 
days or weeks after the onset of stroke before 
gradually subsiding. The median duration of 
visual hallucinations was 28 days and they stated 
that the first 90 days is when spontaneous 
recovery is most likely to occur. 
 
7. LIMITATIONS AND RECOMMENDA-
TIONS FOR FUTURE INCIDENCE, 
PREVALENCE AND RECOVERY 
STUDIES 
 
None of the studies provided information about 
stroke survivors who were not admitted to a 
stroke unit/ward/rehabilitation unit. It is 
acknowledged that a proportion of stroke 
survivors have visual impairment only (usually 
occipital infarcts) but the numbers of these 
remain unknown.  
 
The time of visual examination post stroke has a 
direct effect on the estimate of prevalence of 
visual problems that occur due to stroke. As 
recovery of visual conditions can occur rapidly in 
some cases during the first weeks post stroke, 
studies that assess visual function later than this 
early two week period are likely to detect those 
with persistent visual impairment. The extent of 
visual impairment for those with persistent visual 
conditions may also be misrepresented as           
these individuals may have had substantial 
improvement with only partial deficits remaining. 
Thus there is considerable potential for an 
underestimation of stroke related visual 
impairment. 
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Table 5. Visual perceptual impairment prevalence 
 
Study Design Population Time of vision 
assessment 
Sample 
size (n=) 
Prevalence of 
visual issue (%) 
Co-existent 
ocular 
condition  
Method of 
assessment 
1987; Freeman 
& Rudge [35] 
Prospective 
observation 
General stroke Median within 1 
week of onset 
247 79 – reduced 
stereoacuity 
Yes Orthoptic 
1993; Stone et 
al. [56] 
Prospective General stroke Median within 3 
days of onset 
171 82 – visual neglect 
[right hemisphere] 
65 – visual neglect 
[left hemisphere] 
28 – anosognosia 
[right hemisphere] 
5 – anosognosia [left 
hemisphere] 
Unknown Modified 
behavioural 
inattention test 
1997; Pedersen 
et al. [73] 
Prospective General stroke At admission 1014 23 – visual neglect 
[42 – right 
hemisphere, 8 – left 
hemisphere] 
Unknown Cancellation tasks 
1998; Cassidy 
et al. [79] 
Prospective General stroke 
with left 
hemisphere 
lesions excluded 
Within 7 days and 
monthly follow-up 
66 40.9 – visual neglect  
74 – visual field loss 
Unknown Behavioural 
inattention test 
1999; Cassidy 
et al. [80] 
Prospective General stroke 
with left 
hemisphere 
lesions excluded 
Within 7 days and 
monthly follow-up 
44 61.4 – visual neglect  Unknown Behavioural 
inattention test 
2002; Appleros 
et al. [74] 
Prospective 
retrospective 
cases 
General stroke Unknown 279 23 – visual neglect 
[62 – right 
hemisphere] 
74 – anosognosia 
Unknown Test battery 
2006; Linden et 
al. [75] 
Prospective General stroke At 20 months of 
onset 
243 15 – visual neglect Unknown Star cancellation 
2007; Becker & 
Karnath [76] 
Prospective General stroke Median within 3 
days of onset 
93 26.2 – visual neglect 
[right hemisphere] 
24.3 – visual 
extinction 
Unknown Cancellation tasks 
  
 
 
Hepworth et al.; OR, 5(1): 1-43, 2016; Article no.OR.21767 
 
 
 
20 
 
Study Design Population Time of vision 
assessment 
Sample 
size (n=) 
Prevalence of 
visual issue (%) 
Co-existent 
ocular 
condition  
Method of 
assessment 
2.4 – visual neglect 
[left hemisphere] 
4.9 – visual 
extinction 
2009; Lee et al. 
[78] 
Prospective General stroke 
Left hemisphere 
excluded 
Median within 2 
months of onset 
138 58 – visual neglect 
22.5 – neglect 
dyslexia 
 
Unknown Test battery 
2009; van Nes 
et al. [77] 
Prospective General stroke 
Excluded 
aphasia, gaze 
palsy, cognitive 
issues 
Median within 2 
weeks of onset 
78 21.8 – visual neglect 
88 – right 
hemisphere 
 
Gaze paresis 
excluded 
Cancellation tasks 
2009; Rowe et 
al. [6,24] 
Prospective Stroke survivors 
with suspected 
visual defect 
Median within 3 
weeks of onset 
323 14 – visual neglect 
4 – visual 
hallucinations 
2.5 – visual agnosia 
Yes Test battery 
2013; Beaudoin 
et al. [82] 
Prospective 
longitudinal 
General stroke At discharge to 
home 
189 49.2 – visual 
perceptual defect 
Unknown Motor-free visual 
perceptual test-
vertical version 
2014; 
Chechlacz et al. 
[84] 
Prospective 
observational 
Sub-acute stroke 2.5 – 27.3 days 454 9.1 – left visual 
extinction 
4.6 right visual 
extinction 
Unknown Confrontation 
extinction 
2014; Siong et 
al. [61] 
Prospective 
observational 
General stroke 10 days to 26 years 
post stroke onset 
113 5.3 visual neglect Yes Line bisection 
2014; Yang et 
al. [83] 
Prospective 
observational 
Brainstem 
infarction 
Less than 10 days 
post symptom 
onset 
82 50 – pathologic 
subjective visual 
vertical tilt (>3º) 
76 – ipsiversive 
24 – contraversive 
54.7 – abnormal 
torsion 
Unknown Computerised 
assessment  
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Table 6. Recovery of visual impairment 
 
Study Design Population Time of vision 
assessment 
Sample size (n=) Prevalence of visual issue (%) Assessment  
2013; Ali et al. 
[30] 
Prospective  Stroke trial 
database 
Baseline, 30 days and 
90 days 
11900 at baseline 
4965 at follow-up 
28.2 – visual impairment at 30 days 
20.5 – visual impairment at 90 days 
Versus 60.6 at baseline 
NIHSS 
 
Table 7. Recovery of visual field loss 
 
Study Design Population Time of vision assessment Sample size (n=) Prevalence of visual issue (%) Assessment  
1987; 
Freeman 
& Rudge 
[35] 
Prospective  General stroke Mean 73 day follow-up1 week to 6 
months 
247 33 – improvement (22 full, 11 
partial) 
25 – stable field 
Confrontation 
1989; 
Gray et al. 
[41] 
Prospective General stroke Followed every 24 hours for 4 days 
and max to 28 days 
174 Complete hemianopia: 
17 – full resolution within 2-10 days 
27 – partial improvement 
39 – stable field 
Partial hemianopia: 
44 – full resolution within 48 hours 
28 – full resolution within 14 days 
17 – stable field 
Confrontation 
1991; Tiel 
& Kolmel 
[85] 
Prospective Posterior 
circulation 
stroke 
Excluded 
communication 
difficulty and 
severe 
neurological 
deficits 
Daily follow-up within 3 weeks of 
onset 
125 47.8 – improvement within 6-25 
days  
56.5 for right hemianopia 
56.3 – macula involved with 72.2 
improvement of this 
34.4 – recovery of lower quadrant 
25 – full recovery 
21.9 – recovery of upper quadrant 
18.7 – partial recovery 
Confrontation 
2001; 
Cassidy et 
Prospective General stroke 4 week intervals up to 12 weeks 19 15.8 – full recovery at 4 weeks 
42.1 – central recovery 
Perimetry 
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Study Design Population Time of vision assessment Sample size (n=) Prevalence of visual issue (%) Assessment  
al. [46] 11.1 - stable 
 
2013; Ali 
et al. [30] 
Prospective  Stroke trial 
database 
Baseline, 30 days and 90 days 11900 at baseline 
4965 at follow-up 
Complete hemianopia: 
13 at 30 days 
10 at 90 days 
Versus 35% at baseline 
Partial hemianopia: 
11 at 90 days 
Versus 14.5% at baseline 
NIHSS 
Confrontation 
2006 
Zhang et 
al. [87] 
Retrospective Mixed 
population 
Median 3 months of onset 
Change at 3 and 6 months 
254 3 – full recovery 
34 – partial 
63 – stable field 
Perimetry 
Central 30 or 
24 degrees 
2007; 
Schmielau 
& Wong 
[86] 
Prospective Mixed 
population 
Change at 1 through to 105 months 
post onset 
20 61.5 – improvement Kinetic 
perimetry 
2007; 
Kedar et 
al. [55] 
Retrospective Mixed 
population 
Median 3 days post onset 852 Congruous hemianopia: 
38.1 – improvement 
58.5 – stable field 
3.4 – deteriorated 
Incongruous hemianopia: 
39.6 – improvement 
41.5 – stable field 
18.9 – deteriorated 
Perimetry 
Central 30 or 
24 degrees 
2013c; 
Rowe et 
al. [21] 
Prospective Stroke 
survivors with 
suspected 
visual 
impairment 
Variable over 2 weeks to 6 months 915 7.5 – full recovery 
39.2 – partial recovery  
1 – deterioration 
52.3 – static  
Confrontation 
Static 
perimetry 
Kinetic 
perimetry 
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Table 8. Recovery of eye movement deficits 
 
Study Design Population Time of vision 
assessment 
Sample size 
(n=) 
Prevalence of visual issue (%) Assessment  
1982; De 
Renzi  
et al. [62] 
Prospective General stroke Follow-up every 3-4 
days for 2 weeks post 
onset 
91 8.6 days - mean duration to 
improvement with left stroke 
14.9 – mean duration to improvement 
with right stroke 
NIHSS 
1987; 
Freeman & 
Rudge [35] 
Prospective General stroke Up to 12 months post 
onset 
76 7 – full improvement 
50 – partial improvement 
43 – stable 
92 – improvement in stereoacuity within 
1 month 
Orthoptic 
2011; Rowe  
et al. [18] 
Prospective Stroke survivors 
with suspected 
visual impairment 
Variable over 2 weeks 
to 6 months 
915 Cranial nerve palsy: 
22.5 – full improvement 
43 – partial improvement 
3.5 – deterioration 
Nystagmus: 
42 – partial improvement 
24 – stable 
Gaze palsy: 
4 – full improvement 
66 – partial improvement 
30 - stable 
Orthoptic 
2013; Ali et al. 
[30] 
Prospective  Stroke trial 
database 
Baseline, 30 days and 
90 days 
11900 at 
baseline 
4965 at follow-
up 
Complete gaze palsy: 
– at 30 days 
Versus 14.5% at baseline 
Partial gaze palsy: 
9 – at 30 days 
Versus 31% at baseline 
NIHSS 
Confrontation 
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Table 9. Recovery of central vision deficit 
 
Study Design Population Time of vision assessment Sample size (n=) Prevalence of visual issue (%) Assessment  
1987; Freeman 
& Rudge [35] 
Prospective 
observation 
General stroke Median within 1 week of onset 247 71 – improvement Medical 
Orthoptic 
2011; Rowe et 
al. [19] 
Prospective Stroke survivors 
with suspected 
visual impairment 
Variable over 2 weeks to 6 
months 
915 10.5 – full improvement 
43.4 – partial improvement 
44.7 – stable 
1.3 - deteriorated 
Orthoptic 
 
Table 10. Recovery of visual perceptual impairment 
 
Study Design Population Time of vision assessment Sample size (n=) Prevalence of visual 
issue (%) 
Assessment  
1987; Freeman & 
Rudge [35] 
Prospective General stroke Up to 4 months post onset 247 Visual neglect: 
29 – complete recovery 
57 - stable 
Medical 
Orthoptic 
1998; Cassidy et 
al. [79] 
Prospective General stroke with 
left hemisphere 
lesions excluded 
Monthly follow-up 66 9.1 – visual neglect at 3 
months 
Versus 40.9% at baseline 
Behavioural 
inattention 
test 
2004; Farne et al. 
[88] 
Prospective R hemisphere only Follow-up at 2 weeks and 3 
months post onset 
33 at baseline 
8 at 3 months 
43 – improvement at 2 
weeks [9 – full] 
63 – improvement at 3 
months 
Behavioural 
inattention 
test 
2007; Poggel et al. 
[89] 
Prospective 
 
 
 
Post-geniculate 
lesions 
 
 
Mean 36 months (7-189 
months), up to 6 months 
follow-up. 
 
19 
 
 
 
Visual hallucinations 
persisted for several 
days/weeks and then 
gradually subsided 
Interview 
 
 
 
2007; Poggel et al. 
[89] 
Retrospective 
questionnaire 
Mixed population Up to 6 months follow-up 121 Mean duration of 28 days Questionnaire 
2013; Ali et al. [30] Prospective Stroke trial 
database 
Baseline, 30 days and 90 
days 
11900 at baseline 
4965 at follow-up 
0.6 – visual neglect at 90 
days 
Versus 27.7% at baseline 
NIHSS 
Confrontation 
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Accuracy of non-specialist vision assessments 
and accuracy of screening tools and scores is 
likely to impact on reported prevalence figures. 
Where basic screening is undertaken, it is 
possible to miss subtle visual problems whose 
ocular signs are not included in the screening 
assessment. Thus there is the potential for 
underdiagnoses when the assessment is 
performed by the stroke team rather than an eye 
team specialist or where screening tools are 
used which only measure specific features of 
vision, e.g. detection of hemianopia or horizontal 
gaze defects only as with the NIHSS, or reliance 
on basic confrontation assessment rather than 
detailed confrontation or perimetry assessment.  
 
Studies that report sub populations of stroke 
survivors are also prone to reporting bias for 
visual problems. Despite large sample sizes in 
studies that have included sub populations of 
stroke survivors, such as the VIS study of those 
already suspected of having visual impairment or 
studies of clinical trial databases, these studies 
are unlikely to be representative of the general 
stroke population [6, 30]. These estimates are 
potential under- or over-representations of the 
true prevalence of visual problems across all 
stroke survivors.  
 
The time of the baseline assessment is crucial 
for studies tracking the recovery of visual 
impairment. If the baseline assessment is 
delayed, complete or partial recovery may have 
already taken place. Furthermore, it has not yet 
been accurately established at what time point 
recovery of each visual problem following stroke 
can be expected. If a study only has short period 
of follow-up, recovery could continue after the 
participant has completed the study. Both factors 
result in under-estimation of recovery of stroke-
related visual impairment.  
 
Future studies are required to establish the 
incidence for post-stroke visual impairment in the 
early acute period within the first week of onset. 
Such studies should involve a full stroke cohort 
with no exclusions so that visual impairment 
rates are comprehensively evaluated. These 
patients require follow-up at regular time intervals 
to plot change in visual impairment over the first 
week, first month and longer term after stroke 
onset to provide information on trajectory of 
improvement, if any, and rates for full, partial or 
no recovery. At baseline and follow-up visits, full 
specialist assessment is required such that 
subtle visual deficits that can cause visual 
impairment are not missed. 
8. CONCLUSIONS 
 
The literature currently available for review does 
not include any studies whose primary aim was 
to determine incidence or prevalence of visual 
impairment post stroke. Thus, this review can 
only provide estimates of prevalence for 
individual stroke related visual problems. The 
estimation of the overall prevalence of visual 
impairment was approximately 65% at baseline 
assessment. A reduction to approximately 20% is 
seen by three month post stroke, due to factors 
such as recovery, adaptation and death. The 
figures reported cover a wide range of 
prevalence for each visual problem. A variety of 
factors may be the cause of this wide range of 
figures including; the different study aims, 
research methods used, baseline assessments 
being conducted at different time points and 
different methods assessment. The prevalence is 
reported as being highest for eye movement 
defects, visual field loss and visual inattention. 
The existing literature regarding the recovery of 
visual problems following stroke is scarce for 
both individual deficits and overall visual 
recovery. Further prospective studies are 
required to establish the incidence of post-stroke 
visual impairment, the prevalence at various              
time periods post stroke and trajectory of 
improvement. 
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APPENDIX 
 
Appendix 1 – PRISMA 2009 Checklist 
 
Title  
 
Title  1 Identify the report as a systematic review, meta-analysis, or 
both.  
1 
Abstract  
 
Structured 
summary  
2 Provide a structured summary including, as applicable: 
background; objectives; data sources; study eligibility 
criteria, participants, and interventions; study appraisal and 
synthesis methods; results; limitations; conclusions and 
implications of key findings; systematic review registration 
number.  
1 
Introduction  
 
Rationale  3 Describe the rationale for the review in the context of what is 
already known.  
2 
Objectives  4 Provide an explicit statement of questions being addressed 
with reference to participants, interventions, comparisons, 
outcomes, and study design (PICOS).  
2 
Methods  
 
Protocol and 
registration  
5 Indicate if a review protocol exists, if and where it can be 
accessed (e.g., Web address), and, if available, provide 
registration information including registration number.  
N/A 
Eligibility 
criteria  
6 Specify study characteristics (e.g., PICOS, length of follow-
up) and report characteristics (e.g., years considered, 
language, publication status) used as criteria for eligibility, 
giving rationale.  
2-3 
Information 
sources  
7 Describe all information sources (e.g., databases with dates 
of coverage, contact with study authors to identify additional 
studies) in the search and date last searched.  
Appendix 2 
Search  8 Present full electronic search strategy for at least one 
database, including any limits used, such that it could be 
repeated.  
Appendix 2 
Study 
selection  
9 State the process for selecting studies (i.e., screening, 
eligibility, included in systematic review, and, if applicable, 
included in the meta-analysis).  
2-3 
Data collection 
process  
10 Describe method of data extraction from reports (e.g., 
piloted forms, independently, in duplicate) and any 
processes for obtaining and confirming data from 
investigators.  
4 
Data items  11 List and define all variables for which data were sought (e.g., 
PICOS, funding sources) and any assumptions and 
simplifications made.  
3-4 
Risk of bias in 
individual 
studies  
12 Describe methods used for assessing risk of bias of 
individual studies (including specification of whether this was 
done at the study or outcome level), and how this 
information is to be used in any data synthesis.  
4  
Appendix 5 
Summary 
measures  
13 State the principal summary measures (e.g., risk ratio, 
difference in means).  
N/A 
Synthesis of 
results  
14 Describe the methods of handling data and combining 
results of studies, if done, including measures of consistency 
N/A 
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(e.g., I2) for each meta-analysis.  
Risk of bias 
across studies  
15 Specify any assessment of risk of bias that may affect the 
cumulative evidence (e.g., publication bias, selective 
reporting within studies).  
4 
Additional 
analyses  
16 Describe methods of additional analyses (e.g., sensitivity or 
subgroup analyses, meta-regression), if done, indicating 
which were pre-specified.  
N/A 
Results  
 
Study 
selection  
17 Give numbers of studies screened, assessed for eligibility, 
and included in the review, with reasons for exclusions at 
each stage, ideally with a flow diagram.  
4, Appendix 3 
Study 
characteristics  
18 For each study, present characteristics for which data were 
extracted (e.g., study size, PICOS, follow-up period) and 
provide the citations.  
Tables 1 to 
10 
Risk of bias 
within studies  
19 Present data on risk of bias of each study and, if available, 
any outcome level assessment (see item 12).  
4 
Appendix 5 
Results of 
individual 
studies  
20 For all outcomes considered (benefits or harms), present, for 
each study: (a) simple summary data for each intervention 
group (b) effect estimates and confidence intervals, ideally 
with a forest plot.  
Tables 1 to 
10 
Synthesis of 
results  
21 Present results of each meta-analysis done, including 
confidence intervals and measures of consistency.  
N/A 
Risk of bias 
across studies  
22 Present results of any assessment of risk of bias across 
studies (see Item 15).  
4 
Additional 
analysis  
23 Give results of additional analyses, if done (e.g., sensitivity 
or subgroup analyses, meta-regression [see Item 16]).  
N/A 
Discussion   
Summary of 
evidence  
24 Summarize the main findings including the strength of 
evidence for each main outcome; consider their relevance to 
key groups (e.g., healthcare providers, users, and policy 
makers).  
5-24 
Limitations  25 Discuss limitations at study and outcome level (e.g., risk of 
bias), and at review-level (e.g., incomplete retrieval of 
identified research, reporting bias).  
24-25 
Conclusions  26 Provide a general interpretation of the results in the context 
of other evidence, and implications for future research.  
25 
Funding  
 
Funding  27 Describe sources of funding for the systematic review and 
other support (e.g., supply of data); role of funders for the 
systematic review.  
25 
From: Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009). Preferred Reporting Items for 
Systematic Reviews and Meta-Analyses: The PRISMA Statement. PLoS Med 6(6): e1000097.  
DOI: 10.1371/journal.pmed1000097. Available: www.prisma-statement.org 
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Appendix 2. Search Options and Search Terms 
 
Databases: 
 
• Cochrane Stroke Group Trials Register 
• The Cochrane Eyes and Vision Group Trials Register 
• The Cochrane Central Register of Controlled Trials (CENTRAL) (The Cochrane Library, latest 
issue); 
• MEDLINE (1950 to April 2015); 
• EMBASE (1980 to April 2015); 
• CINAHL (1982 to April 2015); 
• AMED (1985 to April 2015); 
• PsycINFO (1967 April 2015); 
• Dissertations & Theses (PQDT) database (1861 to April 2015); 
• British Nursing Index (1985 to April 2015); 
• PsycBITE (Psychological Database for Brain Impairment Treatment Efficacy, 
www.psycbite.com). 
 
Registers: 
 
• ClinicalTrials.gov (http://clinicaltrials.gov/); 
• Current Controlled Trials (www.controlledtrials. com); 
• Trials Central (www.trialscentral.org); 
• Health Service Research Projects in Progress 
(wwwcf.nlm.nih.gov/hsr_project/home_proj.cfm); 
• National Eye Institute Clinical Studies Database 
(http://clinicalstudies.info.nih.gov/cgi/protinstitute.cgi?NEI.0.html) 
• British and Irish Orthoptic Journal, Australian Orthoptic Journal, and proceedings of the 
European Strabismological Association (ESA), International Strabismological Association 
(ISA), International Orthoptic Association (IOA) 
(http://pcwww.liv.ac.uk/~rowef/index_files/Page646.htm)  
• Proceedings of Association for Research in Vision and Ophthalmology (www.arvo.org); 
 
Terms: 
 
Cerebrovascular disorders/ 
Brain ischaemia/ 
Intracranial Arterial Disease 
Intracranial Arteriovenous Malformations/ 
“Intracranial Embolism and Thrombosis*/ 
Stroke/ 
 
Eye Movements/ 
Eye/ 
Eye Disease/ 
Visually Impaired Persons/ 
Vision Disorders/ 
Blindness/ 
Diplopia/ 
Vision, Binocular/ 
Vision, Monocular/ 
Visual Acuity/ 
Visual Fields/ 
Vision, Low/ 
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Ocular Motility Disorders/ 
Blindness, Cortical/ 
Hemianopsia/ 
Abducens Nerve Diseases/ 
Abducens Nerve/ 
Oculomotor Nerve/ 
Trochlear Nerve/ 
Visual Perception/ 
Nystagmus 
strabismus 
smooth pursuits 
saccades depth perception 
stereopsis gaze disorder 
internuclear opthalmoplegia 
Parinaud’s syndrome 
Weber’s syndrome 
skew deviation 
conjugate deviation oscillopsia 
visual tracking agnosia hallucinations 
OR OR 
AND 
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Appendix 3. Flowchart of Pathway for Inclusion of Articles 
 
 
 
 
 
 
 
Full-text articles retrieved 
and assessed for eligibility  
n = 283 
Excluded n = 21,938 
Not relevant to the 
review 
Excluded n = 152  
(Table 3) 
Not relevant n=32 
Review article n=30 
General population 
n=20 
Case study or small 
case series n=14 
<50% stroke diagnosis 
n=27 
Other non-empirical  
articles n=7 
Visual defects not  
discussed n= 5 
Abstract only n=3 
Insufficient information 
n=7 
Included in Cochrane 
Systematic review n=5 
Duplicate n=2 
 
 
Articles related to visual 
problems following stroke 
n = 131 
Studies identified 
from searching 
reference lists  
n = 31 
Titles identified through 
database searching  
n = 109,281 
Titles and abstracts 
screened  
n = 22,190 
Articles meeting inclusion 
criteria relating to 
prevalence and recovery  
n = 64 
Excluded n = 87,091 
Duplicates 
Case studies 
Editorials 
Letters 
Not Relevant 
 
  
 
 
Hepworth et al.; OR, 5(1): 1-43, 2016; Article no.OR.21767 
 
 
 
35 
 
Appendix 4. Excluded Articles 
 
Study Reason for exclusion 
Ajina and Kennard, 2012  Review article 
Al-Khayat et al., 2005 No stroke patients included 
Anderson and Rizzo, 1994 Case report 
Anderson and Rizzo, 1995 Review article 
Baier at al., 2010 Not relevant to the review – preselected cases 
Barker et al., 2012 Not relevant to the review – assessment of 
neuropsychology 
Barnes et al., 2006 Unable to distinguish number of stroke patients  
Barrett, 2009 Review article 
Bartolomei et al., 1998 No stroke patients included 
Beran and Murphy-Lavoie, 2009  Not related to stroke 
Beck and Harris, 1994 Not related to stroke – general population 
Behrmann et al., 2004 Not relevant to the review – addresses different 
types of search patterns in neglect 
Biousse et al., 1998 Only reported on three patients 
Blythe et al., 1987 Not relevant to the review – preselected cases 
assessed for blindsight 
Bodis-Wollner and Diamond, 1973 Unable to establish the proportion of participants 
were post-stroke, participants reported to have 
cerebral lesions. 
Bodis-Wollner and Diamond, 1976 Unable to establish the proportion of participants 
were post-stroke, participants reported to have 
cerebral lesions.  
Bombois et al., 2007 Stroke patients excluded 
Bronstein et al., 1990 Unable to establish the proportion of participants 
were post-stroke 
Brown Jr et al., 1998 A general population sampled 
Brunette, 1967 Review article 
Bulsara et al., 2007 No stroke patients included 
Bunce and Wormald, 2008 A general population sampled 
Bunce et al., 2010 A general population sampled 
Büttner and Grundei, 1995 Sample included 50% or fewer stroke patients 
Buxbaum et al., 2008 Not relevant to the review – performance on 
wheelchair navigation 
Caneman et al., 1992 Not relevant to the review – performance on maze 
test 
Carlow and Bicknell, 1981 Review article 
Carman-Merrifield, 2005 Review article 
Cheek et al., 1965 Sample included 50% or fewer stroke patients  
Cheung et al., 2008 Not relevant to the review - discussed retinal 
pathology 
Chia et al., 2004 A general population sampled 
Ciuffreda et al., 2006 Sample included 50% or fewer stroke patients 
Ciuffreda et al., 2007 Sample included 50% or fewer stroke patients 
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Clenet, 2011 Case study 
Cockburn, 1983 A general population sampled 
Colombo et al., 1981 Not relevant to the review – preselected cases from 
a larger cohort 
Cooper, 1971 Not relevant to stroke 
Cooper et al., 2012 Only reported on two patients 
Crews et al., 2006 Sample included 50% or fewer stroke patients 
Danta et al., 1978 Sample included 50% or fewer stroke patients 
Das et al., 2007 Review article 
Dennis et al., 1990 Not relevant to the review – transient ischaemic 
attacks 
Di Legge et al., 2004 Correspondence to the editor 
Dulli et al., 1998 No reference to visual problems 
François, 1975 Review article 
Fraser et al., 2011 Review article 
Galanth et al., 2014 Visual problems of stroke patients not discussed 
Gállego et al., 2008 Review article 
Gamio and Melek, 2003 Case report 
George et al., 2011 Protocol article 
Georgiadis et al., 1999 No reference to visual problems 
Gilhotra et al., 2002 A general population sampled 
Gilhotra et al., 2002 A general population sampled 
Giroud et al., 1994 Not relevant to review - focused on seizures after 
stroke 
Globe et al., 2005 A general population sampled 
Goldstein and Simel, 2005 Review article 
Good et al., 2001 Not relevant to review - paediatric population 
Gottlieb and Miesner, 2004 Review article 
Grunda et al., 2013 Review article 
Guenther et al., 2009 Not relevant to the review – evaluating prediction 
model 
Habekost and Starrfelt, 2006 Case report 
Hankey, 1997 A general population sampled 
Hofman et al., 2007 A general population sampled  and study protocol 
update 
Hofman et al., 2011 A general population sampled  and study protocol 
update 
Horton, 2005 Editorial 
Howard et al., 2006 Unable to establish the proportion of participants 
were post-stroke 
Jagger et al., 1989 No stroke patients included 
Jarvis et al., 2012 Not relevant to the review – information provided to 
the stroke team 
Jensen et al., 2009 Case study 
Jin et al., 2010 No stroke patients included 
Jobke et al., 2009 Already included in a Cochrane Systematic Review 
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Jones and Shinton, 2006 Review article 
Jungehülsing et al., 2008 A general population sampled 
Kasten et al., 2007 Sample included 50% or fewer stroke patients 
Kasten et al., 2006 Sample included 50% or fewer stroke patients 
Kerkhoff and Stögerer, 1994 No stroke patients included 
Kim and Kim, 2005 Not relevant to the review – restricted to midbrain 
stroke only 
Kissel et al., 1983 No stroke patients included 
Klavora and Warren, 1998 Not relevant to the review - overview of equipment, 
no participant data presented 
Książkiewicz and Sobczak-Kamińska, 1998 Not relevant to the review - eye assessment related 
to level of consciousness 
Kumar, 2006 News article 
Kuppersmith et al., 1996 No stroke patients included 
Lamoreux et al., 2008 A general population sampled 
Langelaan et al., 2007 A general population sampled 
Leff et al., 2000 Sample included 50% or fewer stroke patients 
Leff and Behrmann, 2008 Review article 
Leśniak and Seniów, 2007 Review article 
Lessell, 1975 Review article 
Levine, 2006 Letter to editor 
Lisabeth et al., 2009 Unable to distinguish with numbers of stroke and 
TIA patients 
Macfarlane and Jolly, 1995 Not relevant to the review – role of the orthoptist 
Markowitz, 2009 Review article 
Marshall et al., 2008 Not relevant to the review - fMRI study 
Marx et al., 1992 A general population sampled 
McKean et al., 2014 Not relevant to the review – predicting factors on 
imaging of stroke 
Mead et al., 2002 Visual problems of stroke patients not discussed 
Merten, 2001 Review article 
Mitchell et al., 1996 A general population sampled  
Nazerian et al., 2014 Sample included 50% or fewer stroke patients 
Nazzarko, 2007 Review article 
Neikter, 1999 Only conference abstract available 
Nelles et al., 2009 Not relevant to the review – training effects on 
neural plasticity 
Niu et al., 2005 Not relevant to the review – examines location of 
lesion for neglect 
Olbert, 1985 Case study 
O’Neill et al., 2011 Sample included 50% or fewer stroke patients 
Pambakian et al., 2005 Review article 
Patel et al., 2004 Sample included 50% or fewer stroke patients 
Patino et al., 2010 A general population sampled 
Pelak et al., 2007 Review article 
Peli, 2000 Sample included 50% or fewer stroke patients 
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Petzold et al., 2013 Not related to stroke patients 
Piechocki, 2004 News article 
Poggel et al., 2004 Already included in a Cochrane Systematic Review 
Proto et al., 2009 Review article 
Purvin, 1996 Review article 
Purvin, 2004 Review article 
Racette and Casson, 2005 Not relevant to the review – impact on driving  
Rafałowska et al., 1972 Only reported on three patients 
Ramrattan et al., 2001 A general population sampled 
Riise, 1969 No stroke patients included 
Ritchie at al., 2012 Only reported on two patients 
Ross, 1983 Not relevant to the review – selected sample 
Rossi et al., 1990 Already included in a Cochrane Systematic Review 
Rowe, 2009 Duplicate – subset sample  
Rowe, 2010 Not relevant to the review 
Rutner et al., 2006 Sample included 50% or fewer stroke patients 
Sabel and Kasten, 2000 Review article 
Sabel and Mueller, 2005 Only abstract available 
Sabel and Trauzettal-Klosinksi, 2005 Expert debate 
Sahraie et al., 2010 Case study 
Sand et al., 2013 Review article 
Schofield and Leff, 2009 Review article 
Schwartz et al., 2012 Not relevant to the review –assessment of eye 
position using CT scan 
Shiraishi et al., 2004 Stroke patients not identified separately 
Simon et al., 2003 Not relevant to the review –assessment of eye 
position using CT scan 
Spitzyna et al., 2007 Already included in a Cochrane Systematic Review 
Suchoff et al., 2008 Sample included 50% or fewer stroke patients 
Tsai et al., 2003 Sample included 50% or fewer stroke patients 
Unwin et al., 1999 Only conference abstract available 
Vahlberg and Hellström, 2008 Review article 
van der Graaff et al., 2000 Case study 
Viken et al., 2014 Not relevant to the review – predicting functional 
outcomes 
Weinberg et al., 1977 Already included in a Cochrane Systematic Review 
Williams et al., 2003 Visual problems not discussed 
Wolter and Preder, 2006 Review article 
Woo and Mandelman, 1983 Case report 
Zhang et al., 2006 Duplicate report of study already included in the 
review 
Zhou et al., 2013 A general population sampled 
Zihl, 1980 Only reported on three patients 
Zihl et al., 1988 Not relevant to the review  
Zihl and Hebel, 1997 Sample included 50% or fewer stroke patients 
Zihl et al., 2009  Not relevant to the review – selected sample 
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Appendix 5. Quality Appraisal of Papers Using the STROBE Checklist 
 
 
I
n
t
r
o
d
u
c
t
i
o
n
 
M
e
t
h
o
d
s
 
R
e
s
u
l
t
s
 
D
i
s
c
u
s
s
i
o
n
 
 3 4 6 7 8 9  10 11 12 13 14 15 16 17 18 19 20 21 
Agrell et al., 1997 [45] 
 
+ + + + + + + + ? - + + + + + - + - 
Akhtar et al., 2009 [68] 
 
+ + + + + - + + + - + + + n/a + - - + 
Ali et al., 2013 [30] 
 
+ + + + + - + - - ? ? + + + + + + + 
Appelros et al., 2002 [74] 
 
+ + + + + + + + + + + + + + + + + + 
Baier and Dieterich, 2011 [67] - + + + + - - - - + + + + n/a + - + + 
Barrett  et al., 2007 [38] 
 
+ + + + - - - + + + + + + + + + + - 
Beaudoin et al., 2013 [82] 
 
+ + + + + + - + - + + + + + + + + + 
Becker and Karnath, 2007 [76] + + + + + - + + - + + + + n/a  - - - 
Benedetti et al. 1993 [48] 
 
+ + + + - - + + - + + + + + + - - + 
Bulens et al 1989 [71] 
 
- + + + + - - + - + + + + + + - - - 
Cassidy et al., 1998 [79] 
 
+ + + + + - + + - - + + + n/a + + + - 
Cassidy et al. 1999 [80] 
 
+ + + + + - - + - + - + + n/a + - + - 
Cassidy et al.,  2001 [46] 
 
+ + + + + + + + - + - + + + + + + - 
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4 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 
Celesia et al., 1997 [54] + + + + + - 
 
+ + - 
 
+ + + + + + - + - 
Chechlacz et al., 2014 [84] 
 
- + - + + + + + + + + + + + + + + + 
Clisby, 1995 [32] 
 
+ - - - - - - - - + - 
 
+ - - - - - - 
De Renzi et al., 1982 [62] 
 
- + + + + + + + - + + + + n/a + - + - 
Dos Santos et al., 2012 [72] 
 
+ - + + + + - 
 
+ + + + + + n/a + + + + 
Edwards et al., 2006 [70] 
 
+ + + + + + - + + + + + + + + - + + 
Farné et al., 2004 [89] 
 
+ + - 
 
+ + - - + + + + + + + + - - - 
Fowler et al., 1996 [58] 
 
+ + + + + - + + - + + + + n/a + - + - 
 
Freeman and Rudge, 1987 [35] + + + + + - + + - + + + + n/a + - - - 
Gall et al., 2010 [31] 
 
+ + + + + + + + + + + + + n/a + + + + 
Gray et al., 1989 [41] 
 
+ + + + + + + + - + + + + n/a + - - - 
Haerer, 1973 [47] 
 
+ + + + - - + - 
 
- + + + + n/a + + + - 
Isaeff et al.,  1974 [33] 
 
- + ? - - - - + - + + + + n/a - - - - 
Jerath et al., 2011 [53] 
 
+ + + + + - 
 
+ + - + + + + n/a + + + + 
Kedar et al., 2007 [55] 
 
+ + + + + + + + + + + + + + + + + - 
Lawrence et al., 2001 [49] + + + + - - + + + + + + + + + - - - 
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 3 4 
 
6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 
Lee et al., 2009 [78] 
 
- 
 
+ + + + - 
 
+ + - 
 
+ + + + + + - 
 
+ - 
Linden et al., 2006 [75] 
 
+ + + + + - + + + + + + + n/a + - + - 
 
Lotery et al., 2000 [64] 
 
+ + + + - 
 
- - 
 
+ - 
 
+ + + + n/a + - - - 
Maeshima et al., 2012 [59] 
 
- 
 
+ + + + - + + + + + + + n/a + - - - 
Ng et al., 2005 [50] 
 
+ + + + + - + + + + + + + + + + + + 
Pedersen et al., 1997 [73] 
 
+ + + + + - + + + + + + + + + - - - 
Poggel et al., 2007 [89] 
 
- + + + + - + + + + + + + + + - - - 
Rathore et al., 2002 [52] 
 
- - 
 
+ + - - + + + + + + + + + + + - 
Rowe, 2007 [69] 
 
+ + + + - - + + + + + + + + + - + + 
Rowe et al., 2008 [66] 
 
+ + + + - - + + - + + + + + + - + + 
Rowe et al., 2009 [24] 
 
+ + + + - - + + - + + + + + + - + + 
Rowe et al., 2009 [6] 
 
+ + + + + - + + - + + + + + + + + + 
Rowe et al., 2010 [23]  
 
+ + + + - 
 
- + + - + + + + + + - 
 
+ - 
 
Rowe et al., 2011 [18] 
 
+ + + + + - + + + + + + + + + + + + 
Rowe et al., 2011 [19] 
 
+ + + + + - + + + + + + + + + + + - 
Rowe et al.,  2013 [36] 
 
+ + + + + - + + + + + + + + + - 
 
+ - 
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 3 
 
4 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 
Rowe et al., 2013 [22] 
 
+ + + + - - + + + + + + + + + + + - 
Rowe et al., 2013 [21] 
 
+ + + + + - + + + + + + + + + + + + 
Schmielau and Wong Jr, 2007 [86] + - 
 
+ + + - - 
 
+ - 
 
+ + + + + + - - - 
Searls et al., 2012 [42] 
 
+ + + + - - + + + + + + + + + - - - 
Shrestha et al., 2012 [81] 
 
+ + + + + - + + + + + + + + + - - - 
Siddique et al., 2009 [65] 
 
- + + - - - + + - 
 
+ + + + + + - 
 
+ + 
Singer et al., 2006 [63] 
 
- + + + - 
 
- + + + + + + + + + + + + 
Siong et al., 2014 [61] 
 
+ + + + + + + + + + + + + + + + + + 
Stone et al., 1993 [56] 
 
+ + + + + - + + + + + + + + + - - - 
Su and Young, 2013 [60] 
 
- 
 
+ + + + - + + - 
 
+ + + - - + - 
 
+ - 
Tao et al., 2012 [43] 
 
+ + + + - - + + + + + + + + + + + - 
Tiel and Kölmel, 1991 [85] 
 
- + + + - - + + - 
 
+ + + - 
 
n/a + - - - 
Townsend et al., 2007 [51] 
 
- + + + + + + + + + + + + n/a + - - + 
Trobe et al.,  1973 [34] 
 
- + + - - - + - - + + + - - + - - - 
van Nes et al., 2009 [77] 
 
+ + + + + + + + + + + + + + + - - - 
Yang et al., 2014 [83] 
 
+ + + + + + + + + + + + + + + - - - 
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4 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 
Yap et al., 1975 [57] 
 
+ + + + - - + + - + + + - 
 
n/a + - - - 
Zhang et al., 2006a [44] 
 
+ + + + + + + + - + + + + + + - 
 
+ + 
Zhang et al., 2006b [87] 
 
+ + + + + + + + - + + + - 
 
n/a + + + + 
 
                                                                                = Not reported;             = Unclear;           = Reported 
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